Abstract
Background and objective
Oral squamous cell carcinoma is the most common form of mouth cancer. As plant-based medicines become increasingly popular, Moringa oleifera has been studied extensively for its plant-based components, and health benefits. The present review examined the anticancer effects of Moringa oleifera extracts on Oral squamous cell carcinoma.
Materials and methods
The study complied with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. A comprehensive search was performed on PubMed, Scopus, and Google Scholar to find research papers published from January 2015 to August 2024 that assessed the effects of extracts of various parts of Moringa oleifera in Oral squamous cell carcinoma. Two independent reviewers separately assessed research study titles, abstracts, and the chosen full-text papers. The risk of bias in non-randomized exposure studies was classified as low, with some concerns high and extremely high.
Results
The final review yielded four in-vitro investigations, two molecular analyses, and five animal models. The study revealed that Moringa oleifera plant components have antioxidant, anti-inflammatory, anticancer, and chemo-preventive properties. All the 11 studies showed a low risk of bias.
Conclusion
The studies reviewed herein reveal that Moringa oleifera plant components have antioxidant, anti-inflammatory, anticancer, and chemopreventive properties. Although more clinical trials are needed to fully establish its efficacy and safety as a complementary therapy, the growing body of evidence positions Moringa oleifera as a promising natural adjunct to cancer treatment strategies.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Saveetha Institute of Medical and Technical Sciences, Chennai, India (GRID:grid.412431.1) (ISNI:0000 0004 0444 045X); Sathyabama Institute of Science and Technology, Chennai, India (GRID:grid.412427.6) (ISNI:0000 0004 1761 0622)
2 Sathyabama Institute of Science and Technology, Chennai, India (GRID:grid.412427.6) (ISNI:0000 0004 1761 0622)
3 Saveetha Institute of Medical and Technical Sciences, Chennai, India (GRID:grid.412431.1) (ISNI:0000 0004 0444 045X)
4 Priyadarshini Dental College and Hospital, Chennai, India (GRID:grid.412431.1)




